Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • DOP

    Tag: DOP

    You Searched For "DOP"
    Govt taking steps to reduce dependence on import of antibiotic raw materials: Minister

    Govt taking steps to reduce dependence on import of antibiotic raw materials: Minister

    Medical Dialogues Bureau16 Feb 2020 11:00 AM IST
    As per the information received from the port offices of the Central Drugs Standard Control Organisation (CDSCO), it stood at 12,006.11 metric tonnes...
    NPPA pulls Gilead on price exemption plea for its Hepatitis B drug

    NPPA pulls Gilead on price exemption plea for its Hepatitis B drug

    Farhat Nasim4 Feb 2020 3:12 PM IST
    New Delhi: The apex drug price regulator, National Pharmaceuticals Pricing Authority (NPPA) has recently sought clarifications from the US-drugmaker...
    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Emcure plea to direct NPPA to review HIV drugs price junked by DoP

    Farhat Nasim3 Feb 2020 1:41 PM IST
    New Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
    DoP rejects Geltec plea to review price of Ibuprofen Capsule fixed by NPPA

    DoP rejects Geltec plea to review price of Ibuprofen Capsule fixed by NPPA

    Farhat Nasim13 Jan 2020 3:44 PM IST
    New Delhi: In a major setback to drugmaker Geltec Private Limited, the Department of Pharmaceuticals (DoP) has junked its review petition against the...
    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected

    Farhat Nasim6 Jan 2020 1:15 PM IST
    New Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
    Minister informs Parliament about steps taken to promote affordable generic drugs

    Minister informs Parliament about steps taken to promote affordable generic drugs

    Medical Dialogues Bureau26 Nov 2019 4:30 PM IST
    New Delhi: The Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently informed the Parliament about the steps taken by the...
    DOP junks Cipla plea to refix MRP of Tafmune–EM

    DOP junks Cipla plea to refix MRP of Tafmune–EM

    Farhat Nasim2 Sept 2019 4:34 PM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    DOP junks Geltec plea against NPPA decision on retail price of Ibuprofen Soft Gelatin Capsules

    Farhat Nasim28 July 2019 11:30 AM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Geltec Private Limited...
    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Refix ceiling price of Zydus Healthcare Tiotropium Inhalation: DoP directs NPPA

    Meghna A Singhania23 Jun 2019 4:57 PM IST
    New Delhi: Allowing the review petition of Zydus Healthcare Limited regarding price fixation of Tiotropium Inhalation (MDI) 9 mcg/dose, the Department...
    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Cipla moves against NPPA for price fixation of asthma drugs; DOP junks plea

    Farhat Nasim16 Jun 2019 11:44 AM IST
    New Delhi: Mumbai-based drugmaker, Cipla Limited's review petition against the Government regulatory agency, National Pharmaceutical Pricing Authority...
    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    DOP Order: NPPA refixes retail price of Trilosar 6.25, 12.5

    Meghna A Singhania6 May 2019 11:23 AM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Launching product without Approval: DOP rejects Biocon Plea against NPPA action

    Launching product without Approval: DOP rejects Biocon Plea against NPPA action

    Meghna A Singhania24 Feb 2019 11:25 AM IST
    New Delhi: Through a recent decision, the Department of Pharmaceuticals rejected the review applications filed by biopharmaceutical major Biocon...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok